Hefei Time Information Technology Co.,Ltd – Trademark Portfolio
Entity Type: 16
Hefei Time Information Technology Co.,Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VESSEYJAM. The owner is based in Hefei.
Room 412,#C Lianhua Technology Park
819 Lianhua Rood
Hefei 230601 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hefei Time Information Technology Co.,Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Hefei Time Information Technology Co.,Ltd have?
Hefei Time Information Technology Co.,Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hefei Time Information Technology Co.,Ltd file in?
Hefei Time Information Technology Co.,Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Hefei Time Information Technology Co.,Ltd's most well-known trademarks?
Hefei Time Information Technology Co.,Ltd's registered trademark portfolio includes well-known marks such as VESSEYJAM. These are among 1 currently registered trademark in the portfolio.
What is Hefei Time Information Technology Co.,Ltd's trademark registration success rate?
Hefei Time Information Technology Co.,Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.